Sign in to view content

Apples and Oranges: "Real-World" Outcomes Differ From Clinical Trial Outcomes Because "Real-World" Patients Differ From Clinical Trial Patients

Franco M. Recchia, MD

Video
Published 2021

Related

Episode 25: RIVAL Study: Ranibizumab vs Aflibercept in T&E for wet AMD with Dr. Mark Gillies
Keyvan Koushan, MD, FRCSC
Member Podcasts
2019
Episode 2: Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration with Dr. Brian Ballio
Keyvan Koushan, MD, FRCSC
Member Podcasts
2017
A Biocompatible Basal Membrane to Restore Age-Related Macular Degeneration Photoreceptor Damage
Stanislao Rizzo, MD
Annual Meeting Talks
2019

Category: AMD-Neovascular

See more